Brind.
  1. Allegations surfaced that FDA officials, including a safety data-mining expert, were involved in oversight failures regarding vaccine safety signals related to Moderna.

Johnson Investigates FDA Records Regarding Moderna Vaccine Adverse Effects

3 reports, 1 independent Updated Oct 22
Gone quiet Reached 3 outlets in its first 24 hours
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Johnson launched an investigation into FDA records concerning Moderna vaccine safety on October 21, 2026. Reports indicate that FDA safety officers compiled a list of children possibly killed by COVID vaccines after reviewing adverse effects and autopsy records for those who died following vaccination with mRNA vaccines from Moderna and Pfizer. The team determined that several adolescents apparently died from the COVID vaccines.

From wnd.com

Why it matters

Some supportBrind's analysis of the reports

The investigation follows allegations that FDA officials failed to adequately oversee vaccine safety signals related to Moderna. A previous FDA safety team leader recommended changing vaccine labels to warn patients of fatal myocarditis, but the FDA had not taken action ten months later.

Allegations surfaced that FDA officials, including a safety data-mining expert, were involved in oversight failures regarding vaccine safety signals related to Moderna.

From wnd.com

Who's involved

  • JohnsonLaunched the investigation into FDA records regarding vaccine safety.
  • FDAThe regulatory agency whose records are being investigated.
  • ModernaManufacturer of mRNA vaccines whose adverse effects are under review.
  • PfizerManufacturer of mRNA vaccines whose adverse effects are under review.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • ModernaSpeculative

    Moderna could face increased regulatory scrutiny, potentially affecting vaccine sales and public demand.

  • PfizerSpeculative

    Pfizer could face increased regulatory scrutiny, potentially affecting vaccine sales and public demand.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
2 more outlets ran the same wire story